Secreted frizzled-related protein 4 (SFRP4), has been recently identified as a potential early biomarker of T2D related to obesity, due to its association with low grade inflammation in adipose tissue and impaired glucose metabolism. Here, SFRP4 is linked to obesity due to melanocortin 4 receptor deficiency.